Free Trial
ASX:EX1

Exopharm (EX1) Stock Price, News & Analysis

About Exopharm Stock (ASX:EX1)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$1.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EX1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exopharm and its competitors with MarketBeat's FREE daily newsletter.

EX1 Stock News Headlines

Tryptamine Therapeutics Ltd (TYP)
New Federal Land Rush About to Start?
A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being quietly opened to the public, and former hedge fund firm manager Whitney Tilson believes this is the best chance in years to turn a small stake into huge gains. He's naming one $10 stock leading this "US: IPO" boom.
EX1 - Weather warnings issued
Exopharm Limited (EX1.XA)
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:EX1
CIK
N/A
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$4.32 million
Net Margins
-1,756.70%
Pretax Margin
N/A
Return on Equity
-160.86%
Return on Assets
-51.37%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.82
Quick Ratio
2.03

Sales & Book Value

Annual Sales
A$1.18 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.39
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
439,420,000
Free Float
N/A
Market Cap
A$1.93 million
Optionable
Not Optionable
Beta
1.26
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (ASX:EX1) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners